Jun 6, 2025 08:01AM
Jun 6, 2025 08:00AM
Nov 13, 2024 04:05PM
Aug 6, 2024 08:13AM
Aug 6, 2024 08:00AM
Sep 27, 2022 04:05PM
May 16, 2022 04:04PM Aytu BioScience (AYTU) Reports Q1 Revenue of $24.2M, Net Loss of $53.1M
May 16, 2022 04:02PM
Feb 15, 2022 06:00AM
Feb 14, 2022 04:08PM
Feb 14, 2022 04:05PM
Jan 4, 2022 08:03AM
Jan 4, 2022 08:00AM
Jan 3, 2022 08:00AM Aytu BioPharma to Present at H.C. Wainwright BioConnect Conference
Dec 13, 2021 08:04AM
Dec 13, 2021 08:00AM
Dec 8, 2021 08:02AM
Dec 8, 2021 08:00AM
Nov 23, 2021 08:02AM
Nov 23, 2021 08:00AM
Nov 17, 2021 08:00AM Aytu BioPharma Ranked Number 178 Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 50(TM)
Nov 15, 2021 04:00PM
Nov 8, 2021 08:05AM
Sep 30, 2021 08:01AM
Sep 27, 2021 04:01PM
Sep 23, 2021 08:00AM
Sep 9, 2021 08:00AM
Sep 7, 2021 08:00AM Aytu BioPharma to Present at Upcoming September Investor Conferences
Jul 27, 2021 08:05AM
Jun 28, 2021 08:53AM
Jun 28, 2021 08:50AM
May 25, 2021 08:01AM
May 17, 2021 04:01PM
May 10, 2021 04:01PM
Apr 12, 2021 08:00AM Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics
Apr 5, 2021 08:04AM
Apr 5, 2021 08:00AM
Apr 1, 2021 07:30AM
Mar 29, 2021 04:03PM
Mar 22, 2021 06:00AM
Mar 8, 2021 04:03PM
Mar 8, 2021 04:01PM Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 Patients
Feb 24, 2021 08:00AM
Feb 23, 2021 04:10PM
Feb 11, 2021 04:01PM
Feb 10, 2021 08:00AM
Feb 10, 2021 08:00AM
Dec 28, 2020 08:09AM
Dec 28, 2020 08:05AM Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 Patients
Dec 15, 2020 12:00PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All